Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Februar 2024 15:44 ET | Quelle: Monteverde & Associates PC

ALERT: The M&A Class Action Firm Launches Investigation of the Merger – WISH, IONM, CBAY, FANG

NEW YORK, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders...
09. März 2020 19:51 ET | Quelle: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Fraud Ongoing

SAN FRANCISCO, March 09, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) who have suffered significant losses to submit their losses now. The...
03. März 2020 12:27 ET | Quelle: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud

SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) who have suffered significant losses to submit their losses now. The...